Integrin α6 (CD49f), The Microenvironment and Cancer Stem Cells.

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer is a leading cause of death globally, affecting millions.
• Cancer stem cells (CSCs) are implicated in tumor initiation, progression, and recurrence.
• Identifying key regulators of CSC activity is vital for developing targeted therapies.

Purpose of the Study:

• To review the literature on stem cells with tumorigenic properties.
• To highlight the role of integrin α6 (ITGA6) in cancer stem cell (CSC) activity.
• To provide evidence for ITGA6's importance in CSC self-renewal and microenvironment interaction.

Main Methods:

• Literature review of studies investigating CSCs and ITGA6.
• Analysis of evidence demonstrating ITGA6's function in CSCs.
• Synthesis of findings on ITGA6's role in CSC self-renewal and microenvironment adhesion.

Main Results:

• Integrin α6 (ITGA6, also known as CD49f) is a key marker for identifying CSC populations across various tissues.
• ITGA6 is essential for maintaining the self-renewal capacity of CSCs.
• ITGA6 facilitates the connection between CSCs and the tumor microenvironment.

Conclusions:

• Integrin α6 (ITGA6) plays a critical role in sustaining cancer stem cell (CSC) self-renewal.
• Targeting ITGA6 may offer a therapeutic strategy to disrupt CSC function and tumor growth.
• Understanding ITGA6's interaction with the tumor microenvironment is crucial for advancing cancer treatment.